Astrocytes regulate the developmental appearance of GABAergic and glutamatergic postsynaptic currents in cultured embryonic rat spinal neurons.
The effects of astrocytes on the emergence of synaptic transients and excitable membrane properties in cultured, embryonic, rat ventral spinal neurons were studied with electrical and optical recording techniques. Neurons on astrocytes had significantly longer neurites and an accelerated rate of growth in surface membrane during the initial 24 h in culture compared to neurons on poly-D-lysine (PDL). GABAergic (GABA, gamma-aminobutyric acid) and glutamatergic transients appeared spontaneously in co-cultured neurons by 24 h. GABAergic quanta did not appear in neurons on PDL until 4 days in culture, and glutamatergic transients did not emerge until 7 days in culture. Astrocyte-conditioned medium (ACM) partially mimicked the effects of direct astrocytic contact. GABAergic transients appeared by 2 days, and glutamatergic signals by 4 days in neurons on PDL exposed to ACM. All of the spontaneous, synaptic-like transients were eliminated by tetrodotoxin or Ca2+o-free saline, implicating voltage-dependent cation channels in their generation. Astrocytes immediately and significantly increased the density of voltage-dependent Na+ currents compared to neurons on PDL, but by the end of 24 h, Na+ current densities were identical. Electrophysiological and optical recording revealed comparable densities of high-voltage-activated (HVA) Ca2+ currents on both co-cultured neurons and neurons on PDL throughout the first week. However, neurons on astrocytes had significantly greater contributions of P/Q-type currents and lesser contributions of L-type currents beginning at 24 h and continuing for 7 days. The contribution of N-type current was significantly more in co-cultured neurons only at 24 h. Thus, in vitro, astrocytes help to differentiate specific excitable membrane properties in spinal neurons, along with GABAergic and glutamatergic forms of synaptic transmission.
Li
Y X
YX
Laboratory of Neurophysiology, National Institute of Neurological Disorders and Stroke, National Institute of Health, Bethesda, MD 20892, USA.
Schaffner
A E
AE
Barker
J L
JL
D000596:Amino Acids / Q000378:metabolism; D000818:Animals; D001253:Astrocytes / Q000502:physiology*; D002118:Calcium / Q000502:physiology; D002470:Cell Survival / Q000502:physiology; D002478:Cells, Cultured; D004553:Electric Conductivity; D004622:Embryo, Mammalian / Q000166:cytology / Q000502:physiology; D005314:Embryonic and Fetal Development / Q000502:physiology; D018698:Glutamic Acid / Q000378:metabolism* / Q000502:physiology; D009474:Neurons / Q000378:metabolism / Q000502:physiology*; D011107:Polylysine; D011188:Potassium / Q000494:pharmacology; D051381:Rats / Q000196:embryology; D017207:Rats, Sprague-Dawley; D012964:Sodium / Q000502:physiology; D013116:Spinal Cord / Q000166:cytology / Q000196:embryology*; D013569:Synapses / Q000378:metabolism / Q000502:physiology*; D016708:Synaptophysin / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism* / Q000502:physiology
D000596:Amino Acids; D016708:Synaptophysin; D011107:Polylysine; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D012964:Sodium; D011188:Potassium; D002118:Calcium